Pre-Market Activity Shows Heavy Volume And Movement For Sabra Health Care REIT (SBRA)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Sabra Health Care REIT ( SBRA) as a pre-market mover with heavy volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Sabra Health Care REIT as such a stock due to the following factors:

  • SBRA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $11.0 million.
  • SBRA traded 54,370 shares today in the pre-market hours as of 8:24 AM, representing 12.6% of its average daily volume.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in SBRA with the Ticky from Trade-Ideas. See the FREE profile for SBRA NOW at Trade-Ideas

More details on SBRA:

Sabra Health Care REIT, Inc. operates as a real estate investment trust in the United States. The company, through its subsidiaries, owns and invests in real estate properties for the healthcare industry. The stock currently has a dividend yield of 5.8%. SBRA has a PE ratio of 21. Currently there are 5 analysts that rate Sabra Health Care REIT a buy, 1 analyst rates it a sell, and 3 rate it a hold.

The average volume for Sabra Health Care REIT has been 345,600 shares per day over the past 30 days. Sabra Health Care REIT has a market cap of $1.6 billion and is part of the financial sector and real estate industry. The stock has a beta of 1.02 and a short float of 4.8% with 5.17 days to cover. Shares are down 11.2% year-to-date as of the close of trading on Tuesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com Analysis:

TheStreet Quant Ratings rates Sabra Health Care REIT as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself.

Highlights from the ratings report include:
  • The revenue growth came in higher than the industry average of 8.4%. Since the same quarter one year prior, revenues rose by 36.0%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • SABRA HEALTH CARE REIT INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, SABRA HEALTH CARE REIT INC increased its bottom line by earning $0.69 versus $0.67 in the prior year. This year, the market expects an improvement in earnings ($1.22 versus $0.69).
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Real Estate Investment Trusts (REITs) industry. The net income increased by 366.3% when compared to the same quarter one year prior, rising from -$7.30 million to $19.45 million.
  • Net operating cash flow has significantly increased by 1946.47% to $24.70 million when compared to the same quarter last year. In addition, SABRA HEALTH CARE REIT INC has also vastly surpassed the industry average cash flow growth rate of 0.89%.
  • The gross profit margin for SABRA HEALTH CARE REIT INC is rather high; currently it is at 60.14%. Regardless of SBRA's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, SBRA's net profit margin of 34.99% compares favorably to the industry average.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

3 Hold-Rated Dividend Stocks: TRGP, SBRA, APO

3 Hold-Rated Dividend Stocks: TRGP, SBRA, APO

These 7 Stocks Are Spiking on Big Volume -- Here's How to Trade Them Now

These 7 Stocks Are Spiking on Big Volume -- Here's How to Trade Them Now

What To Hold: 3 Hold-Rated Dividend Stocks SBRA, PIR, FTR

What To Hold: 3 Hold-Rated Dividend Stocks SBRA, PIR, FTR

Strong On High Volume: Sabra Health Care REIT (SBRA)

Strong On High Volume: Sabra Health Care REIT (SBRA)

3 Hold-Rated Dividend Stocks: CVA, SBRA, GME

3 Hold-Rated Dividend Stocks: CVA, SBRA, GME